Aimei Health Technology Co., Ltd (AFJK)
NASDAQ: AFJK · Real-Time Price · USD
11.00
0.00 (0.00%)
May 13, 2025, 4:00 PM - Market closed
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses.
It intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector.
The company was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd
| Country | United States |
| Founded | 2023 |
| IPO Date | Dec 4, 2023 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street, Suite 3001 New York, New York 10022 United States | |
| Phone | 861 375 8131392 |
Stock Details
| Ticker Symbol | AFJK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001979005 |
| ISIN Number | KYG013411098 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Junheng Xie | Chief Executive Officer, Secretary and Director |
| Heung Ming Wong | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2025 | SCHEDULE 13G/A | Filing |
| May 6, 2025 | 8-K | Current Report |
| Apr 8, 2025 | SCHEDULE 13G | Filing |
| Apr 7, 2025 | 8-K | Current Report |
| Mar 28, 2025 | 10-K | Annual Report |
| Mar 7, 2025 | SCHEDULE 13G/A | Filing |
| Mar 7, 2025 | SCHEDULE 13G/A | Filing |
| Mar 6, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | SCHEDULE 13G | Filing |